NCT03616977View on ClinicalTrials.gov

Study to Compare 2 Formulations of LY900014 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

August 3, 2018

Primary Completion Date

October 19, 2018

Study Completion Date

October 19, 2018

Conditions
Healthy
Interventions
DRUG

LY900014 U-200

Administered SC

DRUG

LY900014 U-100

Administered SC

Trial Locations (1)

138623

Lilly Centre for Clinical Pharmacology, Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03616977 - Study to Compare 2 Formulations of LY900014 in Healthy Participants | Biotech Hunter | Biotech Hunter